Parnassus Investments, LLC Astrazeneca PLC Transaction History
Parnassus Investments, LLC
- $45.6 Billion
- Q3 2024
A detailed history of Parnassus Investments, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Parnassus Investments, LLC holds 7,406 shares of AZN stock, worth $497,535. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,406
Previous 10,012
26.03%
Holding current value
$497,535
Previous $780,000
26.03%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding AZN
# of Institutions
1,361Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.23 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.82 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.5 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.47 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.28 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $208B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...